Relief Therapeutics Holding AG (RLFTF)

[pegs1]

Penny World,
I read a post on this board stated that Relief Therapeutics would be in talks of a phase 2 trial with Aviptadil (I assume inhaler version) for 2023. My question is why phase 2 instead of phase 3? To me the last trial was totally unfair by FDA. The length of the trial should have been longer (at least 7 days)! Why is the NIH so slow releasing the trial data ? Im sorry but I'm frustrated with the FDA! I'm having problems getting into clinical trials. They are wanting histological proof of sarcoidosis . My biopsies showed granuloma cells with sparse fibrosis. So it was inconclusive! I have all the symptoms of sarcoidosis including the horrible plaques! Oh well sorry to vent. ....